Head-to-head for women
REMEVi vs RxSpan MD
REMEVi and RxSpan MD both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
REMEVi
Ranked #17 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViRxSpan MD
Higher scoreRanked #10 for women · Grade B
Luna Fit
Best for: Women who prioritize an accredited, brand-capable program with an oral route and don't mind paying at the higher end.
Visit RxSpan MDThe verdict for women
RxSpan MD edges out REMEVi on the Luna Fit Score, 86 to 85 (B vs B). Women who prioritize an accredited, brand-capable program with an oral route and don't mind paying at the higher end.
REMEVi is still a genuine option — an accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | REMEVi | RxSpan MD |
|---|---|---|
| Luna Fit Score | 85/100 · B | 86/100 · B |
| Overall rank | #17 | #10 |
| Semaglutide | $199/mo | $249/mo |
| Tirzepatide | $269/mo | $329/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Luna Fit
REMEVi
Ranked #17 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Luna Fit
RxSpan MD
Ranked #10 · Grade B
What we like
- FDA-approved brand access, oral option, and both molecules on one account
- LegitScript-accredited, nationwide across all 50 states
- Comprehensive feature set for women who want every option available
The caveats
- Highest-tier pricing among the accredited options — $249 semaglutide, $329 tirzepatide
- General metabolic program, not hormone-specialized
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Luna Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing REMEVi and RxSpan MD against other providers we review for women.
- REMEVi vs CoreAge Rx
- REMEVi vs Eden
- REMEVi vs Ondra Health
- RxSpan MD vs Found
- RxSpan MD vs Vytora Health
- RxSpan MD vs Effecty
Or browse the full comparison hub.